Suven Pharmaceuticals Limited (BOM: 543064)

Market Cap	301.70B
Revenue (ttm)	9.61B
Net Income (ttm)	2.43B
Shares Out	n/a
EPS (ttm)	9.54
PE Ratio	124.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,420
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	586.10 - 1,359.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 5, 2025

About Suven Pharmaceuticals

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 1,193
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543064

Financial Performance

In 2023, Suven Pharmaceuticals's revenue was 10.51 billion, a decrease of -21.56% compared to the previous year's 13.40 billion. Earnings were 3.00 billion, a decrease of -26.99%.